Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients with unresectable liver cancer
-
IDWeek data reinforces AstraZeneca’s commitment to advance science in vaccines and immune therapies
-
Alexion aims to advance NMOSD treatment landscape with exceptional Ultomiris efficacy data at ECTRIMS 2022
-
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type1
-
Tezspire approved in Japan for the treatment of severe asthma
-
Ultomiris approved in Europe for the treatment of adults with generalised myasthenia gravis
-
Lynparza approved in China as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
-
Tezspire approved in the EU for the treatment of severe asthma
-
Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19
-
Beyfortus (nirsevimab) recommended for approval in the EU by CHMP for the prevention of RSV lower respiratory tract disease in infants
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
